DURECT Corp (NASDAQ:DRRX)

CAPS Rating: 2 out of 5

The Company is a pharmaceutical Company developing therapies for the treatment of chronic diseases and conditions with its proprietary drug formulations and delivery platform technologies.

Recs

0
Player Avatar kellon100 (28.22) Submitted: 2/20/2008 2:28:10 PM : Outperform Start Price: $5.26 DRRX Score: -83.92


COMPETENT RESEARCHERS

Featured Broker Partners


Advertisement